Jung I - Search Results

1

Phase II clinical and exploratory biomarker study of dacomitinib in patients with recurrent and/or metastatic squamous cell carcinoma of head and neck.

Kim HS, Kwon HJ, Jung I, Yun MR, Ahn MJ, Kang BW, Sun JM, Kim SB, Yoon DH, Park KU, Lee SH, Koh YW, Kim SH, Choi EC, Koo DH, Sohn JH, Kim B, Kwon NJ, Yun HJ, Lee MG, Lee JH, Kim TM, Kim HR, Kim JH, Paik S, Cho BC. Kim HS, et al. Among authors: jung i. Clin Cancer Res. 2015 Feb 1;21(3):544-52. doi: 10.1158/1078-0432.CCR-14-1756. Epub 2014 Nov 25. Clin Cancer Res. 2015. PMID: 25424851 Clinical Trial.

2

Application of the Western-based adjuvant online model to Korean colon cancer patients; a single institution experience.

Jung M, Kim GW, Jung I, Ahn JB, Roh JK, Rha SY, Chung HC, Kim NK, Kim TI, Shin SJ. Jung M, et al. Among authors: jung i. BMC Cancer. 2012 Oct 12;12:471. doi: 10.1186/1471-2407-12-471. BMC Cancer. 2012. PMID: 23061542 Free PMC article.

3

The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.

Park JS, Lee JS, Kim EY, Jung JY, Kim SK, Chang J, Kim DJ, Lee CY, Jung I, Kim JH, Kim HR, Moon YW, Kim HS, Cho BC, Shim HS. Park JS, et al. Among authors: jung jy, jung i. Lung Cancer. 2015 Jun;88(3):325-31. doi: 10.1016/j.lungcan.2015.03.002. Epub 2015 Mar 9. Lung Cancer. 2015. PMID: 25819384

4

A randomized phase II trial of ERCC1 and RRM1 mRNA expression-based chemotherapy versus docetaxel/carboplatin in advanced non-small cell lung cancer.

Heo SJ, Jung I, Lee CK, Kim JH, Lim SM, Moon YW, Shim HS, Jeong J, Kim JH, Kim HR, Cho BC. Heo SJ, et al. Among authors: jung i. Cancer Chemother Pharmacol. 2016 Mar;77(3):539-48. doi: 10.1007/s00280-016-2968-z. Epub 2016 Jan 25. Cancer Chemother Pharmacol. 2016. PMID: 26811178 Clinical Trial.

5

Clinical Practice Patterns of Radiotherapy in Patients with Hepatocellular Carcinoma: A Korean Radiation Oncology Group Study (KROG 14-07).

Cha H, Park HC, Yu JI, Kim TH, Nam TK, Yoon SM, Yoon WS, Kim JW, Kim MS, Jang HS, Choi Y, Kim JH, Kay CS, Jung I, Seong J. Cha H, et al. Among authors: jung i. Cancer Res Treat. 2017 Jan;49(1):61-69. doi: 10.4143/crt.2016.097. Epub 2016 Jun 13. Cancer Res Treat. 2017. PMID: 27338036 Free PMC article.

6

A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01).

Kim HR, Jang JS, Sun JM, Ahn MJ, Kim DW, Jung I, Lee KH, Kim JH, Lee DH, Kim SW, Cho BC. Kim HR, et al. Among authors: jung i. Oncotarget. 2017 Feb 28;8(9):15943-15951. doi: 10.18632/oncotarget.13056. Oncotarget. 2017. PMID: 27823977 Free PMC article. Clinical Trial.

7

PD-L1 expression on immune cells, but not on tumor cells, is a favorable prognostic factor for head and neck cancer patients.

Kim HR, Ha SJ, Hong MH, Heo SJ, Koh YW, Choi EC, Kim EK, Pyo KH, Jung I, Seo D, Choi J, Cho BC, Yoon SO. Kim HR, et al. Among authors: jung i. Sci Rep. 2016 Nov 14;6:36956. doi: 10.1038/srep36956. Sci Rep. 2016. PMID: 27841362 Free PMC article.

8

Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01).

Kim HR, Jang JS, Sun JM, Ahn MJ, Kim DW, Jung I, Lee KH, Kim JH, Lee DH, Kim SW, Cho BC. Kim HR, et al. Among authors: jung i. Oncotarget. 2017 Aug 14;8(33):55766. doi: 10.18632/oncotarget.20268. eCollection 2017 Aug 15. Oncotarget. 2017. PMID: 28903459 Free PMC article.

9

Concordance of programmed death-ligand 1 expression between primary and metastatic non-small cell lung cancer by immunohistochemistry and RNA in situ hybridization.

Kim HR, Cha YJ, Hong MH, Gandhi M, Levinson S, Jung I, Lee JG, Lee CY, Cho BC, Ha SJ, Shim HS. Kim HR, et al. Among authors: jung i. Oncotarget. 2017 Aug 14;8(50):87234-87243. doi: 10.18632/oncotarget.20254. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152077 Free PMC article.

10

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial.

Lee CK, Jung M, Kim HS, Jung I, Shin DB, Kang SY, Zang DY, Kim KH, Lee MH, Kim BS, Lee KH, Cheong JH, Hyung WJ, Noh SH, Chung HC, Rha SY. Lee CK, et al. Among authors: jung m, jung i. Cancer Res Treat. 2019 Jan;51(1):1-11. doi: 10.4143/crt.2018.028. Epub 2018 Feb 5. Cancer Res Treat. 2019. PMID: 29397659 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,721 results

Search Page

Filters